MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0

CUSIP: 604749AB7

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Debt / NOTE 4.000% 5/0
Market price (% of par)
146.89%
Total 13F principal
$296,659,945
Principal change
-$2,388,663
Total reported market value
$437,996,520
Number of holders
36
Value change
-$2,614,830
Number of buys
20
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 604749AB7?
CUSIP 604749AB7 identifies 604749AB7 - MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 as of Q3 2024

As of 30 Sep 2024, MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 was held by 36 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $296,659,945 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WOLVERINE ASSET MANAGEMENT LLC, READYSTATE ASSET MANAGEMENT LP, MACKAY SHIELDS LLC, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., AMERIPRISE FINANCIAL INC, SSI INVESTMENT MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, and FMR LLC. This page lists 36 institutional bondholders reporting positions for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.